Skip to main content
logo
R&G PharmaStudies Co., Ltd. (SHE:301333)
China flag China · Delayed Price · Currency is CNY
50.70
+3.38 (7.14%)
At close: Aug 4, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2015FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '15 Dec '14 Dec '13
Medical Labs & Research
--721.37M637.52M608.43M
Clinical Trial Technical Services
412.74M375.09M---
Clinical Trial Related and Laboratory Services
438.27M368.92M---
Total
851.01M744.00M721.37M637.52M608.43M

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2015FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '15 Dec '14 Dec '13
China
779.64M664.58M674.39M605.02M576.29M
Overseas
71.37M79.42M46.98M32.50M32.13M
Total
851.01M744.00M721.37M637.52M608.43M